160 related articles for article (PubMed ID: 37590164)
1. Targeted Lysosomal Degradation of Secreted and Cell Surface Proteins through the LRP-1 Pathway.
Loppinet E; Besser HA; Lee CE; Zhang W; Cui B; Khosla C
J Am Chem Soc; 2023 Aug; 145(34):18705-18710. PubMed ID: 37590164
[TBL] [Abstract][Full Text] [Related]
2. Lysosome-targeting chimaeras for degradation of extracellular proteins.
Banik SM; Pedram K; Wisnovsky S; Ahn G; Riley NM; Bertozzi CR
Nature; 2020 Aug; 584(7820):291-297. PubMed ID: 32728216
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras.
Ahn G; Riley NM; Kamber RA; Wisnovsky S; Moncayo von Hase S; Bassik MC; Banik SM; Bertozzi CR
Science; 2023 Oct; 382(6668):eadf6249. PubMed ID: 37856615
[TBL] [Abstract][Full Text] [Related]
4. Targeted Protein Degradation via Lysosomes.
Paudel RR; Lu D; Roy Chowdhury S; Monroy EY; Wang J
Biochemistry; 2023 Feb; 62(3):564-579. PubMed ID: 36130224
[TBL] [Abstract][Full Text] [Related]
5. Conjugation with glucagon like peptide-1 enables targeted protein degradation.
Zhu L; Zhou Y; Zhang B; Luo Y; Fang C; Yan X; Cai Y; Jiang L; Ge J
Bioorg Chem; 2023 Dec; 141():106908. PubMed ID: 37827016
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-LYTACs for Targeted Degradation of Extracellular and Membrane Proteins.
Wu Y; Lin B; Lu Y; Li L; Deng K; Zhang S; Zhang H; Yang C; Zhu Z
Angew Chem Int Ed Engl; 2023 Apr; 62(15):e202218106. PubMed ID: 36722696
[TBL] [Abstract][Full Text] [Related]
7. LYTACs: An Emerging Tool for the Degradation of Non-Cytosolic Proteins.
Ramadas B; Kumar Pain P; Manna D
ChemMedChem; 2021 Oct; 16(19):2951-2953. PubMed ID: 34296796
[TBL] [Abstract][Full Text] [Related]
8. Bispecific Aptamer Chimeras Enable Targeted Protein Degradation on Cell Membranes.
Miao Y; Gao Q; Mao M; Zhang C; Yang L; Yang Y; Han D
Angew Chem Int Ed Engl; 2021 May; 60(20):11267-11271. PubMed ID: 33634555
[TBL] [Abstract][Full Text] [Related]
9. The pathway and targeting signal for delivery of the integral membrane glycoprotein LEP100 to lysosomes.
Mathews PM; Martinie JB; Fambrough DM
J Cell Biol; 1992 Sep; 118(5):1027-40. PubMed ID: 1512288
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in degradation of membrane proteins by PROTACs and alternative targeted protein degradation techniques.
Chen S; Cui J; Chen H; Yu B; Long S
Eur J Med Chem; 2023 Dec; 262():115911. PubMed ID: 37924709
[TBL] [Abstract][Full Text] [Related]
11. Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway.
Ahn G; Banik SM; Bertozzi CR
Cell Chem Biol; 2021 Jul; 28(7):1072-1080. PubMed ID: 33770486
[TBL] [Abstract][Full Text] [Related]
12. Targeted degradation of extracellular secreted and membrane proteins.
Chen X; Zhou Y; Zhao Y; Tang W
Trends Pharmacol Sci; 2023 Nov; 44(11):762-775. PubMed ID: 37758536
[TBL] [Abstract][Full Text] [Related]
13. IGF2 Peptide-Based LYTACs for Targeted Degradation of Extracellular and Transmembrane Proteins.
Mikitiuk M; Barczyński J; Bielski P; Arciniega M; Tyrcha U; Hec A; Lipińska AD; Rychłowski M; Holak TA; Sitar T
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005242
[TBL] [Abstract][Full Text] [Related]
14. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera).
Ji CH; Lee MJ; Kim HY; Heo AJ; Park DY; Kim YK; Kim BY; Kwon YT
Autophagy; 2022 Sep; 18(9):2259-2262. PubMed ID: 35722947
[TBL] [Abstract][Full Text] [Related]
15. Targeted Protein Degradation Mediated by Genetically Engineered Lysosome-Targeting Exosomes.
Wang T; Sun L; Ren T; Hou M; Long Y; Jiang JH; He J
Nano Lett; 2023 Oct; 23(20):9571-9578. PubMed ID: 37823825
[TBL] [Abstract][Full Text] [Related]
16. Increased lysosomal proteolysis counteracts protein accumulation in the proximal tubule during focal segmental glomerulosclerosis.
Nielsen R; Mollet G; Esquivel EL; Weyer K; Nielsen PK; Antignac C; Christensen EI
Kidney Int; 2013 Nov; 84(5):902-10. PubMed ID: 23760285
[TBL] [Abstract][Full Text] [Related]
17. Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs.
Alabi SB; Crews CM
J Biol Chem; 2021; 296():100647. PubMed ID: 33839157
[TBL] [Abstract][Full Text] [Related]
18. Advancing targeted protein degradation for metabolic diseases therapy.
Zhou QQ; Xiao HT; Yang F; Wang YD; Li P; Zheng ZG
Pharmacol Res; 2023 Feb; 188():106627. PubMed ID: 36566001
[TBL] [Abstract][Full Text] [Related]
19. Multivalent Aptamer-Based Lysosome-Targeting Chimeras (LYTACs) Platform for Mono- or Dual-Targeted Proteins Degradation on Cell Surface.
Duan Q; Jia HR; Chen W; Qin C; Zhang K; Jia F; Fu T; Wei Y; Fan M; Wu Q; Tan W
Adv Sci (Weinh); 2024 May; 11(17):e2308924. PubMed ID: 38425146
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like Growth Factor 2-Tagged Aptamer Chimeras (ITACs) Modular Assembly for Targeted and Efficient Degradation of Two Membrane Proteins.
Tian Y; Miao Y; Guo P; Wang J; Han D
Angew Chem Int Ed Engl; 2024 Jan; 63(5):e202316089. PubMed ID: 38059276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
